Active Ingredient: SUMATRIPTAN
Proprietary Name: SUMATRIPTAN
Dosage Form; Route of Administration: SPRAY; NASAL
Strength: 20MG/SPRAY
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A213465
Product Number: 001
Approval Date: Sep 21, 2020
Applicant Holder Full Name: PADAGIS ISRAEL PHARMACEUTICALS LTD
Marketing Status:
Prescription
Patent and Exclusivity Information